Whitehawk Therapeutics, Inc.
WHWK
$2.97-1.66%
End of day · as of Oct 14, 2026, 8:00 PM ET
Mkt cap
$202.76M
EV/Sales
23.1
P/E ratio
N/A
FY2025 Revenue
$7.14M
EPS (TTM)
$-1.21
Gross Margin (FY2025)
89.36%
Profit Margin (FY2025)
-288.26%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Whitehawk Therapeutics, Inc. (WHWK) is a biotechnology company listed on NASDAQ.
Latest reported WHWK revenue for 2025-12-31 was $7.1M. Net income was -$20.6M. Revenue was down 72.5% from 2024-12-31 to 2025-12-31. WHWK currently screens at market cap $202.8M.
Use this WHWK research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full WHWK income, balance, and cash tables.
Whitehawk Therapeutics, Inc. (WHWK) is a biotechnology company in the Healthcare sector.
Latest cached Whitehawk Therapeutics, Inc. (WHWK) revenue for Dec 31, 2025 was $7.1M. Net income was -$20.6M. Statements: https://lician.com/financials/whwk
Whitehawk Therapeutics, Inc. (WHWK) market capitalization is $202.8M on the latest cached snapshot.
Whitehawk Therapeutics, Inc. (WHWK) cached previous close $3.02; day range $2.96 – $3.05; volume 510,059. Session quote: https://lician.com/quote/whwk
Whitehawk Therapeutics, Inc. (WHWK) latest cached earnings event is "WHWK earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached WHWK filing is 8-K · Sep 10, 2026. Filings: https://lician.com/sec/whwk